The impact of smoking on inhaled insulin

Diabetes Care

Volumn 26, Issue 3, 2003, Pages 677-682

  Himmelmann, Anders ^a   Jendle, Johan ^b   Mellén, Anders ^a   Petersen, Astrid H ^b   Dahl, Ulf L ^b   Wollmer, Per ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NOVO NORDISK A S   (Denmark)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; OBSERVER VARIATION; RANDOMIZED CONTROLLED TRIAL; SMOKING;

ADMINISTRATION, INHALATION; ADULT; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; SMOKING;

EID: 0038248882     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.3.677     Document Type: Article

References (27)

1. DCCT Research Group: The absence of a glycemic threshold for development of long-term complications: the perspective of the DCCT. Diabetes 45:1289-1298, 1996
2. American Diabetes Association: Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 21:2180-2184, 1998
3. Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA: Efficacy of inhaled insulin in type 1 diabetes mellitus: a randomised proof-of-concept study. Lancet 357:331-335, 2001
4. Heinemann L, Pfützner A, Heise T: Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. Curr Pharm Des 7: 1327-1351, 2001
5. Laube BL, Benedict GW, Dobs AS: The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. Chest 114:1734-1739, 1998
6. Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA: Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial. Diabetes Care 24:1556-1559, 2001
7. Hompesch M, Kapitza C, Scharling B, Thomsen LK, Heise T: Intra-subject variability of pulmonary insulin via the AERx insulin Diabetes Management System versus subcutaneous insulin. Diabetologia 44 (Suppl. 1):A212, 2001
8. Brunner GA, Balent B, Ellmerer M, Schaupp L, Siebenhofer A, Jendle JH, Okikawa J, Pieber TR: Dose-response relation of liquid aerosol inhaled insulin in type 1 diabetic patients. Diabetologia 44:305-308, 2001
9. Haire-Joschu D, Glasgow R, Tibbs T: Smoking and diabetes. Diabetes Care 22:1887-1898, 1999
10. American Thoracic Society: Cigarette smoking and health. Am J Respir Crit Care Med 153:861-865, 1996
11. Witten ML, Lemen RJ, Quan SF, Sobonya RE, Roseberry H, Stevenson JL, Clayton J: Acute cigarette smoke exposure increases alveolar permeability in rabbits. Am Rev Respir Dis 132:321-325, 1985
12. Jones JG, Minty BD, Lawlor P, Hulands G, Crawley JC, Weall N: Increased alveolar epithelial permeability in cigarette smokers. Lancet 1:66-68, 1980
13. Schmekel B, Borgström L, Wollmer P: Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers. Thorax 46:225-228, 1991
14. Miller LG: Cigarettes and drug therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharm 9:125-135, 1990
15. Wise SD, Sathirakul K, Yeo KP, Chien JY, Aftring RP: Smoking increases the bioavailability of inhaled insulin but relative insulin resistance ameliorates differences in action. Diabetologia 44 (Suppl. 1):A5, 2001
16. Heise T, Scharling B, Bellaire S, Tusek C, Bott S: Dose-response of pulmonary insulin with the AERx insulin Diabetes Management System in healthy subjects. Diabetologia 44 (Suppl. 1):A212, 2001
17. Owens DR: Human Insulin: Clinical Pharmacological Studies in Normal Man. Lancaster, UK, MTP Press, 1986
18. Lehr HA: Microcirculatory dysfunction induced by cigarette smoking. Microcirculation 7:367-384, 2000
19. Nieman GF, Clark WR Jr, Paskanik AM, Bredenberg CE, Hakim TS: Unilateral smoke-inhalation increases pulmonary blood flow to the injured lung. J Trauma 36:617-623, 1994
20. Li XY, Rahman I, Donaldson K, MacNee W: Mechanisms of cigarette smoke induced increased airspace permeability. Thorax 51:465-471, 1996
21. Schmekel B, Bos JAH Kahn R, Lachmann B, Venge P, Wollmer P: Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. Thorax 47:603-608, 1992
22. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YDI, Reaven GM: Insulin resistance and cigarette smoking. Lancet 339:1128-1130, 1992
23. Attvall S, Fowelin J, Lager I, Von Schenk H, Smith U: Smoking induces insulin resistance: a potential link with the insulin resistance syndrome. J Intern Med 233:327-332, 1993
24. Nakanishi N, Nakamura K, Matsuo Y, Suzuki K, Tatara K: Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med 133:183-191, 2000
25. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E: Cigarette smoking and insulin resistance in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 82:3619-3624, 1997
26. Minty BD, Jordan C, Jones JG: Rapid improvement in abnormal pulmonary epithelial permeability after stopping smoking cigarettes. BMJ 282:1183-1186, 1981
27. Klemp P, Staberg B, Madsbad S, Kolendorf K: Smoking reduces insulin absorption from subcutaneous tissue. BMJ 284:237, 1982